Markets:

Overview

News

Currencies

International

Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

18.38 +0.18 (+0.99%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel

June 24, 2026

From Johnson Fistel, PLLP

Via Business Wire

Halper Sadeh LLC is Investigating Whether ALOT, SLP, OLN are Obtaining Fair Deals for their Shareholders

June 23, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit

June 23, 2026

From Simulations Plus, Inc.

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)

June 22, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SLP, LPRO, HUN are Obtaining Fair Deals for their Shareholders

June 19, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Simulations Plus, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – SLP

June 18, 2026

From DJS Law Group

Via Business Wire

Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP

June 18, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether SLP, ROKU, TBRG are Obtaining Fair Deals for their Shareholders

June 16, 2026

From Halper Sadeh LLC

Via GlobeNewswire

SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm

June 16, 2026

From Schall Law Firm

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)

June 16, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

SLP Stock Alert: Halper Sadeh LLC is Investigating Whether Simulations Plus, Inc. is Obtaining a Fair Price for its Shareholders

June 16, 2026

From Halper Sadeh LLC

Via Business Wire

Simulations Plus to Be Acquired by Altaris For Approximately $375 Million

June 16, 2026

From Simulations Plus, Inc.

Via Business Wire

SLP INVESTIGATION ALERT: Johnson Fistel Continues Investigation of Simulations Plus, Inc. Following Guidance Cut, Impairment Charge, and Auditor Disclosures

June 15, 2026

From Johnson Fistel, PLLP

Via Business Wire

Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute

June 02, 2026

From Johnson Fistel, PLLP

Via Business Wire

Robbins LLP is Investigating Allegations that the Officers and Directors of Simulations Plus, Inc. (SLP) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

June 01, 2026

From Robbins LLP

Via Business Wire

Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference

May 21, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows

May 06, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

April 21, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

April 20, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results

April 09, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date

March 26, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling

March 26, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD

March 03, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

February 09, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in Upcoming Investor Conferences

February 03, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day

January 21, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

January 08, 2026

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development

December 18, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

December 17, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions

December 09, 2025

From Simulations Plus, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.